IP Verse

Treatment Of Paroxysmal Nocturnal Hemoglobinuria Patients By An Inhibitor Of Complement - EP3167888B1

PatentPatent Analysis

EP3167888

ALEXION PHARMACEUTICALS
Application Number
EP16195355A
Filing Date
Mar 15, 2007
Status
Granted And Under Opposition
Mar 29, 2024
Grant Date
May 1, 2024
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP2894165B1
EP2978451B1
EP3207132B1

Bibliography

The patent EP3167888B1 was granted to Alexion Pharmaceuticals on May 1, 2024 following the initial filing on Mar 15, 2007 under the application number EP16195355A . The current legal status of the patent is Granted And Under Opposition.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

SALUTE HC ILAC PAZARLAMAJan 31, 2025ADMISSIBLE
AMGEN TECHNOLOGY IRELAND UNLIMITEDOct 28, 2024ADMISSIBLE
SAMSUNG BIOEPIS NLMay 2, 2024ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents